Registration
SIDLEY AUSTIN LLP for ACTELION PHARMACEUTICALS US, INC.
Firm
Income
—
Expenses
—
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Taxation/Internal Revenue Code TAX
Advocacy efforts with Congress and the Treasury Department relating to section 9008 of the Patient Protection and Affordable Care Act (Public Law 111-148), which creates an annual fee for manufacturers of branded prescription drugs based on sales to federal government health programs.
| Lobbyist | Covered position, as disclosed |
|---|---|
| PETER M GOODLOE New | Legislative Counsel; House Energy & Commerce ; ; Legislative Counsel; House Office of Legislative |
| WILLIAM A SARRAILLE New | N/A |
Foreign entities
Foreign owners and affiliates the filer disclosed. Amounts are as declared on this filing.
| Entity | Country | Principal place of business | Ownership | Contribution declared |
|---|---|---|---|---|
| ACTELION PHARMACEUTICALS LTD. | Switzerland | Switzerland | 100.0% | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.